English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [3927]
News [11457]
Articles [47]
Editorials [10]
Conferences [200]
elearning [4]
Study unlocks breakthrough for breast cancer bone metastases
Study unlocks breakthrough for breast cancer bone metastases
Researchers develop a light-responsive novel drug delivery system against skin cancer
Researchers develop a light-responsive novel drug delivery system against skin cancer
mRNA therapeutic successfully combats ovarian cancer in mice
mRNA therapeutic successfully combats ovarian cancer in mice
ASCO GU 2024: Combination of cabozantinib and atezolizumab offers hope for patients with type of advanced prostate cancer with poor prognosis
ASCO GU 2024: Combination of cabozantinib and atezolizumab offers hope for patients with type of advanced prostate...
New study finds plant-rich foods, nuts/seeds may reduce premature ageing in childhood cancer survivors
New study finds plant-rich foods, nuts/seeds may reduce premature ageing in childhood cancer survivors
Cancer GPS method evaluates model tumour malignancy
Cancer GPS method evaluates model tumour malignancy
Molecular profiles of tissue plus circulating tumour DNA can better guide cancer care
Molecular profiles of tissue plus circulating tumour DNA can better guide cancer care
What factors affect patients’ decisions regarding active surveillance for low-risk prostate cancer?
What factors affect patients’ decisions regarding active surveillance for low-risk prostate cancer?
FDA approves erdafitinib for locally advanced or metastatic urothelial carcinoma
FDA approves erdafitinib for locally advanced or metastatic urothelial carcinoma
ASCO GI 2024: Adding immunotherapy-based combination to TACE improves progression-free survival in patients with most common liver cancer
ASCO GI 2024: Adding immunotherapy-based combination to TACE improves progression-free survival in patients with...
<1...183184185186187...1146>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top